Peptide-Based Subunit Vaccine against Hookworm Infection
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Hookworms infect more people than HIV and malaria combined, predominantly in third world countries. Treatment of infection with chemotherapy can have limited efficacy and re-infections after treatment are common. Heavy infection often leads to debilitating diseases. All these factors suggest an urgent need for development of vaccine. In an attempt to develop a vaccine targeting the major human hookworm, Necator americanus, a B-cell peptide epitope was chosen from the apical enzyme in the hemoglobin digestion cascade, the aspartic protease Na-APR-1. The A(291)Y alpha helical epitope is known to induce neutralizing antibodies that inhibit the enzymatic activity of Na-APR-1, thus reducing the capacity for hookworms to digest hemoglobin and obtain nutrients. A(291)Y was engineered such that it was flanked on both termini by a coil-promoting sequence to maintain native conformation, and subsequently incorporated into a Lipid Core Peptide (LCP) self-adjuvanting system. While A(291)Y alone or the chimeric epitope with or without Freund's adjuvants induced negligible IgG responses, the LCP construct incorporating the chimeric peptide induced a strong IgG response in mice. Antibodies produced were able to bind to and completely inhibit the enzymatic activity of Na-APR-1. The results presented show that the new chimeric LCP construct can induce effective enzyme-neutralising antibodies in mice, without the help of any additional toxic adjuvants. This approach offers promise for the development of vaccines against helminth parasites of humans and their livestock and companion animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Self-Adjuvanting Lipopeptide Vaccines
Moyle, P., & Toth, I. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783503249 · Cited by 155 · cited 1×
“The self-adjuvanting Lipid Core Peptide (LCP) delivery system has a demonstrated ability to induce strong immune responses against the incorporated peptide-epitopes without the help of external adjuvants, and is considered to be a capable platform for development of human vaccines [13,14].”
Pearson, M. S., Bethony, J. M., Pickering, D. A., de Oliveira, L. M., Jariwala, A., Santiago, H., Miles, A. P., Zhan, B., Jiang, D., Ranjit, N., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-131433 · Cited by 88 · cited 6×
“burdens and a reduction in blood loss was observed [8,10].”
BackgroundMethodInfluentialSelf-citation
Cited by
Recent progress in adjuvant discovery for peptide-based subunit vaccines
Azmi, F., Ahmad Fuaad, A. A. H., Skwarczynski, M., & Toth, I. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27332 · Cited by 239
“LCP constructs were reported as vaccine candidates against wide a range of diseases including GAS,(144) cancer,(145) malaria,(146) and hookworm.(19) Other lipid moieties such as palmatic acid derivatives (Pam3Cys and Pam2Cys), O-acyl serine, N-acyl lysine, and glycolipid compounds that were found to stimulate innate i…”
BackgroundToll-like receptor agonists: a patent review (2011 - 2013)
Hussein, W. M., Liu, T.-Y., Skwarczynski, M., & Toth, I. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.880691 · Cited by 68
“Many microbial components can also be recognized by TLR2 itself, including polysaccharides from different bacterial strains, lipopeptides, lipoarabinomannans, lipomannans, glycosylphosphatidylinositol, lipoteichoic acid, and a range of proteins including lipoproteins and glycoproteins, zymosan and peptidoglycan [56-60…”
BackgroundLipopeptides for Vaccine Development
Hamley, I. W. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00258 · Cited by 62
Madge, H. Y. R., Sharma, H., Hussein, W. M., Khalil, Z. G., Capon, R. J., Toth, I., & Stephenson, R. J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00203 · Cited by 19
Metadata
- Authors
- Skwarczynski, M., Dougall, A. M., Khoshnejad, M., Chandrudu, S., Pearson, M. S., Loukas, A., & Toth, I.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-03
- Volume
- 7
- Issue
- 10
- Pages
- e46870
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1994667037
- Cited by
- 41
- References
- 2
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peptide-Based Subunit Vaccine against Hookworm Infection. https://app.cochat.ai/papers/10.1371/journal.pone.0046870
- The paper
- Skwarczynski, M., Dougall, A. M., Khoshnejad, M., Chandrudu, S., Pearson, M. S., Loukas, A., & Toth, I. (2012). Peptide-Based Subunit Vaccine against Hookworm Infection. PLoS ONE. https://doi.org/10.1371/journal.pone.0046870
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.